December 04, 2018 –  The American Food and Drug Administration (FDA) has just approved its first ever treatment, Amifampridine (Firdapse), for Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder for adult patients. LEMS affects the connection between nerves and muscles …

First ever treatment for Lambert-Eaton myasthenic syndrome (LEMS) FDA approved Read more »

October 9, 2009 –  The American Food and Drug Administration (FDA) has just published the list below with the names of drug products and potential signals of serious risks/new safety information that were identified for these products during the period …

FDA: Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between January – March 2009 Read more »